Cargando…

Association Between Smoking and SARS-CoV-2 Infection: Cross-sectional Study of the EPICOVID19 Internet-Based Survey

BACKGROUND: Several studies have reported a low prevalence of current smoking among hospitalized COVID-19 cases; however, no definitive conclusions can be drawn. OBJECTIVE: We investigated the association of tobacco smoke exposure with nasopharyngeal swab (NPS) test results for SARS-CoV-2 infection...

Descripción completa

Detalles Bibliográficos
Autores principales: Prinelli, Federica, Bianchi, Fabrizio, Drago, Gaspare, Ruggieri, Silvia, Sojic, Aleksandra, Jesuthasan, Nithiya, Molinaro, Sabrina, Bastiani, Luca, Maggi, Stefania, Noale, Marianna, Galli, Massimo, Giacomelli, Andrea, Antonelli Incalzi, Raffaele, Adorni, Fulvio, Cibella, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081027/
https://www.ncbi.nlm.nih.gov/pubmed/33668011
http://dx.doi.org/10.2196/27091
_version_ 1783685555900383232
author Prinelli, Federica
Bianchi, Fabrizio
Drago, Gaspare
Ruggieri, Silvia
Sojic, Aleksandra
Jesuthasan, Nithiya
Molinaro, Sabrina
Bastiani, Luca
Maggi, Stefania
Noale, Marianna
Galli, Massimo
Giacomelli, Andrea
Antonelli Incalzi, Raffaele
Adorni, Fulvio
Cibella, Fabio
author_facet Prinelli, Federica
Bianchi, Fabrizio
Drago, Gaspare
Ruggieri, Silvia
Sojic, Aleksandra
Jesuthasan, Nithiya
Molinaro, Sabrina
Bastiani, Luca
Maggi, Stefania
Noale, Marianna
Galli, Massimo
Giacomelli, Andrea
Antonelli Incalzi, Raffaele
Adorni, Fulvio
Cibella, Fabio
author_sort Prinelli, Federica
collection PubMed
description BACKGROUND: Several studies have reported a low prevalence of current smoking among hospitalized COVID-19 cases; however, no definitive conclusions can be drawn. OBJECTIVE: We investigated the association of tobacco smoke exposure with nasopharyngeal swab (NPS) test results for SARS-CoV-2 infection and disease severity accounting for possible confounders. METHODS: The nationwide, self-administered, cross-sectional web-based Italian National Epidemiological Survey on COVID-19 (EPICOVID19) was administered to an Italian population of 198,822 adult volunteers who filled in an online questionnaire between April 13 and June 2, 2020. For this study, we analyzed 6857 individuals with known NPS test results. The associations of smoking status and the dose-response relationship with a positive NPS test result and infection severity were calculated as odds ratios (ORs) with 95% CIs by means of logistic and multinomial regression models adjusting for sociodemographic, clinical, and behavioral characteristics. RESULTS: Out of the 6857 individuals (mean age 47.9 years, SD 14.1; 4516/6857, 65.9% female), 63.2% (4334/6857) had never smoked, 21.3% (1463/6857) were former smokers, and 15.5% (1060/6857) were current smokers. Compared to nonsmokers, current smokers were younger, were more educated, were less affected by chronic diseases, reported COVID-19–like symptoms less frequently, were less frequently hospitalized, and less frequently tested positive for COVID-19. In multivariate analysis, current smokers had almost half the odds of a positive NPS test result (OR 0.54, 95% CI 0.45-0.65) compared to nonsmokers. We also found a dose-dependent relationship with tobacco smoke: mild smokers (adjusted OR [aOR] 0.76, 95% CI 0.55-1.05), moderate smokers (aOR 0.56, 95% CI 0.42-0.73), and heavy smokers (aOR 0.38, 95% CI 0.27-0.53). This inverse association also persisted when considering the severity of the infection. Current smokers had a statistically significantly lower probability of having asymptomatic (aOR 0.50, 95% CI 0.27-0.92), mild (aOR 0.65, 95% CI 0.53-0.81), and severe infections (aOR 0.27, 95% CI 0.17-0.42) compared to those who never smoked. CONCLUSIONS: Current smoking was negatively associated with SARS-CoV-2 infection with a dose-dependent relationship. Ad hoc experimental studies are needed to elucidate the mechanisms underlying this association. TRIAL REGISTRATION: ClinicalTrials.gov NCT04471701; https://clinicaltrials.gov/ct2/show/NCT04471701
format Online
Article
Text
id pubmed-8081027
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-80810272021-05-06 Association Between Smoking and SARS-CoV-2 Infection: Cross-sectional Study of the EPICOVID19 Internet-Based Survey Prinelli, Federica Bianchi, Fabrizio Drago, Gaspare Ruggieri, Silvia Sojic, Aleksandra Jesuthasan, Nithiya Molinaro, Sabrina Bastiani, Luca Maggi, Stefania Noale, Marianna Galli, Massimo Giacomelli, Andrea Antonelli Incalzi, Raffaele Adorni, Fulvio Cibella, Fabio JMIR Public Health Surveill Original Paper BACKGROUND: Several studies have reported a low prevalence of current smoking among hospitalized COVID-19 cases; however, no definitive conclusions can be drawn. OBJECTIVE: We investigated the association of tobacco smoke exposure with nasopharyngeal swab (NPS) test results for SARS-CoV-2 infection and disease severity accounting for possible confounders. METHODS: The nationwide, self-administered, cross-sectional web-based Italian National Epidemiological Survey on COVID-19 (EPICOVID19) was administered to an Italian population of 198,822 adult volunteers who filled in an online questionnaire between April 13 and June 2, 2020. For this study, we analyzed 6857 individuals with known NPS test results. The associations of smoking status and the dose-response relationship with a positive NPS test result and infection severity were calculated as odds ratios (ORs) with 95% CIs by means of logistic and multinomial regression models adjusting for sociodemographic, clinical, and behavioral characteristics. RESULTS: Out of the 6857 individuals (mean age 47.9 years, SD 14.1; 4516/6857, 65.9% female), 63.2% (4334/6857) had never smoked, 21.3% (1463/6857) were former smokers, and 15.5% (1060/6857) were current smokers. Compared to nonsmokers, current smokers were younger, were more educated, were less affected by chronic diseases, reported COVID-19–like symptoms less frequently, were less frequently hospitalized, and less frequently tested positive for COVID-19. In multivariate analysis, current smokers had almost half the odds of a positive NPS test result (OR 0.54, 95% CI 0.45-0.65) compared to nonsmokers. We also found a dose-dependent relationship with tobacco smoke: mild smokers (adjusted OR [aOR] 0.76, 95% CI 0.55-1.05), moderate smokers (aOR 0.56, 95% CI 0.42-0.73), and heavy smokers (aOR 0.38, 95% CI 0.27-0.53). This inverse association also persisted when considering the severity of the infection. Current smokers had a statistically significantly lower probability of having asymptomatic (aOR 0.50, 95% CI 0.27-0.92), mild (aOR 0.65, 95% CI 0.53-0.81), and severe infections (aOR 0.27, 95% CI 0.17-0.42) compared to those who never smoked. CONCLUSIONS: Current smoking was negatively associated with SARS-CoV-2 infection with a dose-dependent relationship. Ad hoc experimental studies are needed to elucidate the mechanisms underlying this association. TRIAL REGISTRATION: ClinicalTrials.gov NCT04471701; https://clinicaltrials.gov/ct2/show/NCT04471701 JMIR Publications 2021-04-28 /pmc/articles/PMC8081027/ /pubmed/33668011 http://dx.doi.org/10.2196/27091 Text en ©Federica Prinelli, Fabrizio Bianchi, Gaspare Drago, Silvia Ruggieri, Aleksandra Sojic, Nithiya Jesuthasan, Sabrina Molinaro, Luca Bastiani, Stefania Maggi, Marianna Noale, Massimo Galli, Andrea Giacomelli, Raffaele Antonelli Incalzi, Fulvio Adorni, Fabio Cibella, EPICOVID19 Working Group. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org), 28.04.2021. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Public Health and Surveillance, is properly cited. The complete bibliographic information, a link to the original publication on https://publichealth.jmir.org, as well as this copyright and license information must be included.
spellingShingle Original Paper
Prinelli, Federica
Bianchi, Fabrizio
Drago, Gaspare
Ruggieri, Silvia
Sojic, Aleksandra
Jesuthasan, Nithiya
Molinaro, Sabrina
Bastiani, Luca
Maggi, Stefania
Noale, Marianna
Galli, Massimo
Giacomelli, Andrea
Antonelli Incalzi, Raffaele
Adorni, Fulvio
Cibella, Fabio
Association Between Smoking and SARS-CoV-2 Infection: Cross-sectional Study of the EPICOVID19 Internet-Based Survey
title Association Between Smoking and SARS-CoV-2 Infection: Cross-sectional Study of the EPICOVID19 Internet-Based Survey
title_full Association Between Smoking and SARS-CoV-2 Infection: Cross-sectional Study of the EPICOVID19 Internet-Based Survey
title_fullStr Association Between Smoking and SARS-CoV-2 Infection: Cross-sectional Study of the EPICOVID19 Internet-Based Survey
title_full_unstemmed Association Between Smoking and SARS-CoV-2 Infection: Cross-sectional Study of the EPICOVID19 Internet-Based Survey
title_short Association Between Smoking and SARS-CoV-2 Infection: Cross-sectional Study of the EPICOVID19 Internet-Based Survey
title_sort association between smoking and sars-cov-2 infection: cross-sectional study of the epicovid19 internet-based survey
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081027/
https://www.ncbi.nlm.nih.gov/pubmed/33668011
http://dx.doi.org/10.2196/27091
work_keys_str_mv AT prinellifederica associationbetweensmokingandsarscov2infectioncrosssectionalstudyoftheepicovid19internetbasedsurvey
AT bianchifabrizio associationbetweensmokingandsarscov2infectioncrosssectionalstudyoftheepicovid19internetbasedsurvey
AT dragogaspare associationbetweensmokingandsarscov2infectioncrosssectionalstudyoftheepicovid19internetbasedsurvey
AT ruggierisilvia associationbetweensmokingandsarscov2infectioncrosssectionalstudyoftheepicovid19internetbasedsurvey
AT sojicaleksandra associationbetweensmokingandsarscov2infectioncrosssectionalstudyoftheepicovid19internetbasedsurvey
AT jesuthasannithiya associationbetweensmokingandsarscov2infectioncrosssectionalstudyoftheepicovid19internetbasedsurvey
AT molinarosabrina associationbetweensmokingandsarscov2infectioncrosssectionalstudyoftheepicovid19internetbasedsurvey
AT bastianiluca associationbetweensmokingandsarscov2infectioncrosssectionalstudyoftheepicovid19internetbasedsurvey
AT maggistefania associationbetweensmokingandsarscov2infectioncrosssectionalstudyoftheepicovid19internetbasedsurvey
AT noalemarianna associationbetweensmokingandsarscov2infectioncrosssectionalstudyoftheepicovid19internetbasedsurvey
AT gallimassimo associationbetweensmokingandsarscov2infectioncrosssectionalstudyoftheepicovid19internetbasedsurvey
AT giacomelliandrea associationbetweensmokingandsarscov2infectioncrosssectionalstudyoftheepicovid19internetbasedsurvey
AT antonelliincalziraffaele associationbetweensmokingandsarscov2infectioncrosssectionalstudyoftheepicovid19internetbasedsurvey
AT adornifulvio associationbetweensmokingandsarscov2infectioncrosssectionalstudyoftheepicovid19internetbasedsurvey
AT cibellafabio associationbetweensmokingandsarscov2infectioncrosssectionalstudyoftheepicovid19internetbasedsurvey
AT associationbetweensmokingandsarscov2infectioncrosssectionalstudyoftheepicovid19internetbasedsurvey